Stock XCYT XCYTE DIGITAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Xcyte Digital Corp.

Equities

XCYT

CA9839891046

Market Closed - Toronto S.E.
Other stock markets
 15:20:26 2024-07-15 EDT 		5-day change 1st Jan Change
0.165 CAD 0.00% Intraday chart for Xcyte Digital Corp. -2.94% +37.50%
07-10 Xcyte Digital Corp. completed the acquisition of All of the Assets of Webinar.net from Webinar.net CI
06-13 Xcyte Digital Corp. share exchange agreement to acquire 5% stake in MCON Live Inc. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Xcyte Digital Corp. completed the acquisition of All of the Assets of Webinar.net from Webinar.net
CI
Xcyte Digital Corp. share exchange agreement to acquire 5% stake in MCON Live Inc.
CI
Xcyte Digital Corp. entered into a asset purchase agreement to acquire Online Business of MCON Live Inc.
CI
Xcyte Digital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CI
Xcyte Digital Corp. Releases "Xperience" Subscription Service
CI
Xcyte Digital Corp. signed an asset purchase agreement acquire All of the Assets of Webinar.net from Webinar.net.
CI
Xcyte Digital Corp. acquired Assets of A+ Conferencing LLC for $0.5 million.
CI
Xcyte Digital Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
Xcyte Digital Corp. completed the acquisition of GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) from Noetic Psychedelic Fund LP, managed by Noetic Fund in a reverse merger transaction
CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Xcyte Digital Corp. signed a letter of intent to acquire GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) from Noetic Psychedelic Fund LP, managed by Noetic Fund in a reverse merger transaction for CAD 0.13 million.
CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
GHP Noetic Science-Psychedelic Pharma Inc. and Diamond Therapeutics Announces Termination of Letter of Intent
CI
Diamond Therapeutics Inc. cancelled the acquisition of GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) in a reverse merger transaction.
CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
GHP Noetic Science-Psychedelic Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XCYT Stock
  4. News Xcyte Digital Corp.
  5. Highlights